Skip to main content
All lobbying filings

Astellas Pharma US, Inc.

Astellas Pharma US, Inc. filed a Q1 report for Astellas Pharma US, Inc. on April 21, 2025.

Lobbying for Astellas Pharma US, Inc.

As filed: ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.

All filings by Astellas Pharma US, Inc. · Everything Astellas Pharma US, Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$560,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Illinois

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Medicare/Medicaid

Transparency Policy Issues, Medicare Part D, Coverage Gap, Rebate Reform, Out-of-Pocket Costs; H.R. 1300/S. 297 PSA screening bills; Issues related to IRA (Pub. L 117-169); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills).

Health Issues

Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Patient Policy Issues (no specific bills); Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 1300/S. 297, PSA screening bills; Issues related to Women's Health (no specific bills); Issues related to Eye Screening and Access (no specific bills); Issues related to menopause; Issues related to implementation of the Inflation Reduction Act (H.R. 5376).

Copyright/Patent/Trademark

Issues related to IP/Bayh-Dole Act (Pub.L. 96-517).

Insurance

Issues related to Pharmacy Benefit Manager reform, S. 392 Give Kids a Chance Act; Issues pertaining to Current Procedural Terminology (CPT) codes (no specific bills); H.R. 1300/S. 297, PSA screening bills; Issues related to Women's Health (no specific bills); Issues related to Eye Screening and Access (no specific bills).

 Bills named in this filing 4
  • H.R. 1300
    PSA Screening for HIM Act
  • S. 297
    PSA Screening for HIM Act
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act
  • S. 392
    Sloan Canyon Conservation and Lateral Pipeline Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem